Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose ...
Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...
The benefits of early TAVR for patients with asymptomatic, severe aortic stenosis are consistent regardless of NT-proBNP or ...
Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic stenosis ...
The following is a summary of "A new guiding strategy for treating the free margin of the leaflet in an aortic root ...
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.